London: GSK plc has concluded the acquisition of efimosfermin alfa from Boston Pharmaceuticals in a USD 2 billion ...

GSK completes $2 billion acquisition of efimosfermin from Boston Pharmaceuticals: London, UK Wednesday, July 9, 2025, 09:00 Hrs [IST] GSK plc announced the completion of its previ ...

Exposure to a common fungal molecule can reprogram immune cells in the lungs, causing them to overreact to infection-like ...

A compound found in fungal cell walls can reprogram immune cells in the lungs, potentially worsening inflammation during infections.

What if your brain is the reason some pain feels unbearable? Scientists at the Salk Institute have discovered a hidden brain ...

Fibromyalgia is a chronic syndrome that can cause widespread pain in the body. Learn more about the condition, including its symptoms, causes, and treatments.

If you’ve been brushing off persistent fatigue frequent headaches or unexplained weight changes your body might be telling ...

Latest medical research on lung disease. Learn about the symptoms of chronic obstructive pulmonary disease (COPD), emphysema, and lung cancer along with the latest treatment information.

A research group led by Dr. Keisuke Obara, Dr. Kento Yoshioka, and Professor Yoshio Tanaka from the Department of Chemical ...

Pain is common among patients with IIMs and is linked to worse physical function, increased fatigue, and reduced quality of life.